Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes-Reference-Cited by-同舟云学术

Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes

Published:2016-07-04 Issue:1 Volume:16 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Olsen Jan Roger^ORCID,Azeem Waqas,Hellem Margrete Reime,Marvyin Kristo,Hua Yaping,Qu Yi,Li Lisha,Lin Biaoyang,Ke XI-Song,Øyan Anne Margrete,Kalland Karl-Henning

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-016-2453-4

Reference75 articles.

1. Yokoyama NN, Shao S, Hoang BH, Mercola D, Zi X. Wnt signaling in castration-resistant prostate cancer: implications for therapy. Am J Clin Exp Urol. 2014;2(1):27–44.

2. Lu-Yao GL, Albertsen PC, Moore DF, Shih W, Lin Y, DiPaola RS, Yao SL. Fifteen-year survival outcomes following primary androgen-deprivation therapy for localized prostate cancer. JAMA Intern Med. 2014;174(9):1460–7.

3. Rane JK, Pellacani D, Maitland NJ. Advanced prostate cancer--a case for adjuvant differentiation therapy. Nat Rev Urol. 2012;9(10):595–602.

4. Heidenreich A, Pfister D, Merseburger A, Bartsch G, German Working Group on Castration-Resistant Prostate C. Castration-resistant prostate cancer: where we stand in 2013 and what urologists should know. Eur Urol. 2013;64(2):260–5.

5. Nouri M, Ratther E, Stylianou N, Nelson CC, Hollier BG, Williams ED. Androgen-targeted therapy-induced epithelial mesenchymal plasticity and neuroendocrine transdifferentiation in prostate cancer: an opportunity for intervention. Front Oncol. 2014;4:370.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The influence of sex hormones on renal cell carcinoma;Therapeutic Advances in Medical Oncology;2024-01

2. Induction of promyelocytic leukemia zinc finger protein by miR-200c-3p restores sensitivity to anti-androgen therapy in androgen-refractory prostate cancer and inhibits the cancer progression via down-regulation of integrin α3β4;Cellular Oncology;2023-03-30

3. TRIM59 is suppressed by androgen receptor and acts to promote lineage plasticity and treatment-induced neuroendocrine differentiation in prostate cancer;Oncogene;2022-12-21

4. Nonmalignant AR-positive prostate epithelial cells and cancer cells respond differently to androgen;Endocrine-Related Cancer;2022-12-01

5. Induction of promyelocytic leukemia zinc finger protein by miR-200c-3p restores sensitivity to anti-androgen therapy in androgen-refractory prostate cancer and inhibits the cancer progression via down-regulation of integrin α3β4;2022-10-20